GR3004471T3 - - Google Patents
Info
- Publication number
- GR3004471T3 GR3004471T3 GR920400738T GR920400738T GR3004471T3 GR 3004471 T3 GR3004471 T3 GR 3004471T3 GR 920400738 T GR920400738 T GR 920400738T GR 920400738 T GR920400738 T GR 920400738T GR 3004471 T3 GR3004471 T3 GR 3004471T3
- Authority
- GR
- Greece
- Prior art keywords
- group
- carbon atoms
- represents hydrogen
- novel compounds
- alkylsulphonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/22—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU876131A HU207051B (en) | 1987-12-30 | 1987-12-30 | Process for producing 4-chloro-3-sulfamoylbenzoic acid hydrazides and pharmaceutical compositions comprising such compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3004471T3 true GR3004471T3 (el) | 1993-03-31 |
Family
ID=10971250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920400738T GR3004471T3 (el) | 1987-12-30 | 1992-04-30 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4916149A (el) |
| EP (1) | EP0324988B1 (el) |
| JP (1) | JPH01213269A (el) |
| CN (1) | CN1037336A (el) |
| AT (1) | ATE75467T1 (el) |
| AU (1) | AU609682B2 (el) |
| CA (1) | CA1332739C (el) |
| CS (1) | CS277585B6 (el) |
| DD (1) | DD283383A5 (el) |
| DE (1) | DE3870601D1 (el) |
| DK (1) | DK727488A (el) |
| ES (1) | ES2034149T3 (el) |
| FI (1) | FI886045A (el) |
| GR (1) | GR3004471T3 (el) |
| HU (1) | HU207051B (el) |
| IE (1) | IE63246B1 (el) |
| IL (1) | IL88735A (el) |
| NO (1) | NO172285C (el) |
| NZ (1) | NZ227481A (el) |
| PH (1) | PH25739A (el) |
| PL (2) | PL157971B1 (el) |
| PT (1) | PT89368B (el) |
| RU (2) | RU1838303C (el) |
| SU (1) | SU1736339A3 (el) |
| UA (1) | UA19123A (el) |
| YU (1) | YU47125B (el) |
| ZA (1) | ZA889729B (el) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0581904T3 (da) * | 1991-04-01 | 1997-12-29 | Univ Duke | Fremgangsmåde til inhibering af fibrose |
| FR2708608B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant. |
| DE10132896A1 (de) * | 2001-07-06 | 2003-01-16 | Bayer Cropscience Ag | Heterocyclische Amidderivate |
| DE102005002130A1 (de) * | 2005-01-17 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1122541B (de) * | 1959-12-28 | 1962-01-25 | Hoechst Ag | Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren |
| DE1158927B (de) * | 1961-09-15 | 1963-12-12 | Werner Rahms | Grubenstempel |
| DE2144908C2 (de) * | 1971-09-08 | 1982-12-09 | Hoechst Ag, 6000 Frankfurt | 5-(3- oder 4-Aminobenzolsulfonylamino)-benzimidazolone-(2) und Verfahren zu ihrer Herstellung |
| BE793718A (fr) * | 1972-01-07 | 1973-07-05 | Merck & Co Inc | Aminobenzimidazoles |
| DE2247828A1 (de) * | 1972-09-29 | 1974-04-04 | Hoechst Ag | Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung |
| US4420487A (en) * | 1978-04-10 | 1983-12-13 | The Purdue Frederick Company | Diuretic and antihypertensive benzimidazoles |
-
1987
- 1987-12-30 HU HU876131A patent/HU207051B/hu not_active IP Right Cessation
-
1988
- 1988-12-20 IL IL88735A patent/IL88735A/xx not_active IP Right Cessation
- 1988-12-22 NZ NZ227481A patent/NZ227481A/en unknown
- 1988-12-23 DD DD88323775A patent/DD283383A5/de not_active IP Right Cessation
- 1988-12-28 PH PH37991A patent/PH25739A/en unknown
- 1988-12-29 CA CA000587184A patent/CA1332739C/en not_active Expired - Fee Related
- 1988-12-29 ZA ZA889729A patent/ZA889729B/xx unknown
- 1988-12-29 US US07/295,925 patent/US4916149A/en not_active Expired - Fee Related
- 1988-12-29 DK DK727488A patent/DK727488A/da not_active Application Discontinuation
- 1988-12-29 JP JP63335692A patent/JPH01213269A/ja active Pending
- 1988-12-30 PT PT89368A patent/PT89368B/pt not_active IP Right Cessation
- 1988-12-30 AT AT88121901T patent/ATE75467T1/de not_active IP Right Cessation
- 1988-12-30 DE DE8888121901T patent/DE3870601D1/de not_active Expired - Fee Related
- 1988-12-30 YU YU240188A patent/YU47125B/sh unknown
- 1988-12-30 EP EP88121901A patent/EP0324988B1/de not_active Expired - Lifetime
- 1988-12-30 UA UA4613207A patent/UA19123A/uk unknown
- 1988-12-30 PL PL1988276889A patent/PL157971B1/pl unknown
- 1988-12-30 NO NO885830A patent/NO172285C/no unknown
- 1988-12-30 CS CS889108A patent/CS277585B6/cs unknown
- 1988-12-30 SU SU884613207A patent/SU1736339A3/ru active
- 1988-12-30 PL PL1988282492A patent/PL158049B1/pl unknown
- 1988-12-30 FI FI886045A patent/FI886045A/fi not_active Application Discontinuation
- 1988-12-30 IE IE389288A patent/IE63246B1/en not_active IP Right Cessation
- 1988-12-30 CN CN88108996A patent/CN1037336A/zh active Pending
- 1988-12-30 AU AU27631/88A patent/AU609682B2/en not_active Ceased
- 1988-12-30 ES ES198888121901T patent/ES2034149T3/es not_active Expired - Lifetime
-
1989
- 1989-05-10 RU SU894613991A patent/RU1838303C/ru active
- 1989-10-20 RU SU894742151A patent/RU1830064C/ru active
-
1992
- 1992-04-30 GR GR920400738T patent/GR3004471T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6064394A (en) | Adhesion receptor antagonists | |
| FR2691707B1 (fr) | Derives de l'acide dithiophosphorique comme additifs de lubrifiants. | |
| MY105344A (en) | New sulphonyl compounds | |
| ES2193241T3 (es) | Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| IE851205L (en) | Beta-carbolines | |
| DE69837213D1 (de) | Kosmetische zusammensetzung | |
| AU583543B2 (en) | New adamantanamine derivatives, processes for their preparation and drugs in which they are present | |
| GR3004471T3 (el) | ||
| ES2038668T3 (es) | Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica. | |
| AU2240388A (en) | Azachromane derivatives | |
| AU3764585A (en) | 3-alkoxy-2(n-pyrrolidino)-n-pyridyl-n-furyl (or thienyl) methyl propylamines | |
| FI960588A (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä | |
| CA2110132A1 (en) | Inorganic/organic inhibitor for corrosion of iron containing materials in sulfur environment |